IRulya Therapeutics Inc.: insider trading
197 trades by 24 directors, officers and 10% owners since 2019, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$174 K
1 sale by 1 insider
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (24)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| John MilitelloChief Financial Officer | 80,000 | — | — | |
| Luca BenattiDirector | 39,179 | — | $174 K | |
| Dirk ThyeCEO and CMO, Director | 255,000 | — | — | |
| Brendan HannahCBO, COO & CCO | 361,827 | — | — | |
| Charles S. RyanPresident | 130,009 | — | — | |
| David LamondDirector | 2.30 M | — | — | |
| Margaret McLoughlinDirector | 8,000 | — | — | |
| Ted MonohonChief Accounting Officer & VP | 27,440 | — | — | |
| Caryn Gordon McDowellChief Legal & Adm. Officer | 122,500 | — | — | |
| Leslie HolsingerEVP, Preclinical Development | 148,080 | — | — | |
| Karen L. SmithChief Medical Officer | 194,690 | — | — | |
| Philip S. LowDirector | 455,309 | — | — | |
| Christopher P. LoweInterim CEO, COO & CFO | 265,000 | — | — | |
| Michael J. DetkeChief Medical Officer | 140,000 | — | — | |
| Casey LynchChief Executive Officer, Director | 109,895 | — | — | |
| Stephen S. DominyChief Scientific Officer, Director | — | — | — | |
| Chad BoedingManaging Member of Managing Me | 2.84 M | — | — | |
| Pfizer Strategic Investment Holdings LLC10% owner | 2.88 M | — | — | |
| EPIQ Capital Group, LLCIA/Managing Member of 10% owne | 2.85 M | — | — | |
| Christine Lamond10% owner | — | — | — | |
| Kevin YoungDirector | 30,000 | — | — | |
| Pfizer Ventures (US) LLC10% owner | 3.25 M | — | — | |
| Takeda Pharmaceutical Co LTD10% owner | 2.68 M | — | — | |
| Una S. RyanDirector | — | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Luca BenattiDirector | Sell | -50,000 | $3.470 | $174 K | 39,179 | Form 4 |
| filed | Ted MonohonChief Accounting Officer & VP | Sell10b5-1 plan | -1,871 | $0.980 | $2 K | 27,440 | Form 4 |
| filed | Caryn Gordon McDowellChief Legal & Adm. Officer | Sell | -10,800 | $2.860 | $31 K | 122,500 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -1,000 | $88.93 | $89 K | 0 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -4,963 | $98.50 | $489 K | 60,000 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -3,056 | $94.55 | $289 K | 2,944 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -9,158 | $94.23 | $863 K | 42,842 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -7,335 | $95.02 | $697 K | 35,507 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -1,044 | $95.57 | $100 K | 1,900 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -2,330 | $96.32 | $224 K | 33,177 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -1,429 | $96.51 | $138 K | 471 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -1,100 | $97.28 | $107 K | 32,077 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -423 | $97.55 | $41 K | 48 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -48 | $98.90 | $5 K | 0 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -2,077 | $98.90 | $205 K | 30,000 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -10,000 | $100.00 | $1.0 M | 0 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -3,934 | $53.24 | $209 K | 13,466 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -1,648 | $54.37 | $90 K | 11,818 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -4,353 | $55.38 | $241 K | 7,465 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -6,942 | $56.27 | $391 K | 523 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -523 | $56.99 | $30 K | 0 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -32,313 | $53.43 | $1.7 M | 8,548 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -8,260 | $53.91 | $445 K | 288 | Form 4 |
| filed | Michael J. DetkeChief Medical Officer | Sell10b5-1 plan | -288 | $55.01 | $16 K | 0 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -7,724 | $53.39 | $412 K | 12,276 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -7,079 | $54.13 | $383 K | 5,197 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -4,153 | $55.11 | $229 K | 1,044 | Form 4 |
| filed | Christopher P. LoweCOO & Chief Financial Officer | Sell10b5-1 plan | -1,044 | $56.16 | $59 K | 0 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -200 | $55.01 | $11 K | 350 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -250 | $55.03 | $14 K | 100 | Form 4 |
| filed | Margaret McLoughlinDirector | Sell10b5-1 plan | -100 | $55.73 | $6 K | 0 | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -13,584 | $33.75 | $458 K | 995,190 | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -9,918 | $34.89 | $346 K | 985,272 | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -6,315 | $35.81 | $226 K | 978,957 | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -183 | $36.73 | $7 K | 978,774 | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -11,211 | $35.10 | $394 K | 1.03 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -18,089 | $35.85 | $648 K | 1.01 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -300 | $36.58 | $11 K | 1.01 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -400 | $36.60 | $15 K | 1.01 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -400 | $37.39 | $15 K | 1.06 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -1,600 | $38.64 | $62 K | 1.06 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -856 | $39.82 | $34 K | 1.06 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -2,000 | $40.84 | $82 K | 1.05 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -3,100 | $41.91 | $130 K | 1.05 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -1,512 | $43.10 | $65 K | 1.05 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -1,900 | $44.22 | $84 K | 1.05 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -8,032 | $45.00 | $361 K | 1.04 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -600 | $45.73 | $27 K | 1.04 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -14,929 | $36.02 | $538 K | 1.06 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -5,071 | $36.75 | $186 K | 1.06 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -4,686 | $34.60 | $162 K | 1.09 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -3,100 | $35.59 | $110 K | 1.09 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -7,460 | $36.56 | $273 K | 1.08 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -4,283 | $37.68 | $161 K | 1.08 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -100 | $38.28 | $4 K | 1.08 M | Form 4 |
| filed | Casey LynchChief Executive Officer, Director | Sell10b5-1 plan · indirect | -371 | $39.23 | $15 K | 1.08 M | Form 4 |
| filed | Leslie HolsingerExecutive Vice President | Sell10b5-1 plan | -1,700 | $28.80 | $49 K | 41,800 | Form 4 |
| filed | Leslie HolsingerExecutive Vice President | Sell10b5-1 plan | -14,275 | $30.15 | $430 K | 27,525 | Form 4 |
| filed | Leslie HolsingerExecutive Vice President | Sell10b5-1 plan | -13,200 | $30.91 | $408 K | 14,325 | Form 4 |
| filed | Leslie HolsingerExecutive Vice President | Sell10b5-1 plan | -9,525 | $31.79 | $303 K | 1,800 | Form 4 |
| filed | Leslie HolsingerExecutive Vice President | Sell10b5-1 plan | -400 | $32.59 | $13 K | 4,400 | Form 4 |
| filed | Leslie HolsingerExecutive Vice President | Sell10b5-1 plan | -900 | $32.59 | $29 K | 3,500 | Form 4 |
| filed | Pfizer Strategic Investment Holdings LLC10% owner | Sell | -370,000 | $40.18 | $14.9 M | 2.88 M | Form 4 |